Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

Twice as common in men as in women, it can begin at any time, including childhood. Many sufferers are unaware they have it. The symptoms are often noticed first by a partner. As well as heavy snoring, ...

Usain Bolt is colloquially known as the fastest man alive, but the Jamaican may need to get a new moniker after the emergence of a 16-year-old sprinter from Australia. Enter the conversation, Gout ...